Skip to content

Author

Chang-Qing Liu

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Infliximab treatment affects the serum expression of matrix metalloproteinases MMP-2 and MMP-9 in Crohn's disease via the NLRP3 pathway, mediated by extracellular vesicle-derived RAGE

Infliximab modulates the balance of MMP- 2 and MMP-9 in CD patients, at least partly through inhibition of the EV-derived RAGE/NLRP3 inflammasome pathway, which may provide new therapeutic strategies and biomarkers for personalized treatment in Crohn’s disease.

Wei Li, Si-Si Chen, Wei Sun et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.